RIL
ACTU

Rothschild Investment LLC’s Actuate Therapeutics ACTU Stock Holding History

Rothschild Investment LLC’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36 Buy
+13
New +$54 ﹤0.01% 3502

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rothschild Investment LLC's ACTU Position: Q1 2026 in Review

Rothschild Investment LLC opened a new position in Actuate Therapeutics (ACTU) in Q1 2026: 13 shares worth $36. The stake represents ﹤0.01% of the portfolio and ranks #3502 among its holdings.

61 funds tracked by Wall St. Rank hold ACTU as of Q1 2026.

  • Rothschild Investment LLC held 13 shares of Actuate Therapeutics worth $36 as of Q1 2026.
  • Actuate Therapeutics was a new Rothschild Investment LLC position in Q1 2026.
  • Actuate Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #3502 holding.
  • 61 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.